Rapid hematopoietic recovery with high levels of DSA in an unmanipulated haploidentical transplant patient

Transplantation

Volumn 95, Issue 12, 2013, Pages

  Ishiyama, Kenichi ^a   Anzai, Naoyuki ^a   Tashima, Masaro ^a   Hayashi, Kouji ^b   Saji, Hiroh ^b  

^a TAKATSUKI RED CROSS HOSPITAL   (Japan)

^b Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FLUDARABINE; HLA ANTIBODY; HLA CLASS 1 ANTIBODY; HLA CLASS 2 ANTIBODY; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; MELPHALAN; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CASE REPORT; CHIMERA; DONOR SELECTION; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOASSAY; IMMUNOPROPHYLAXIS; LETTER; LEUKOCYTE COUNT; MOLECULAR DYNAMICS; MYELOABLATIVE CONDITIONING; MYELOID LEUKEMIA; PRIORITY JOURNAL;

FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE;

EID: 84880104130     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318293fcda     Document Type: Letter

References (15)

1. Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010; 116: 2839.
2. Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010; 115: 2704.
3. Ciurea SO, Lima M, Cano P, et al. High risk of graft failure in patients with anti-HLA-antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009; 88: 1019.
4. Yoshihara S, Maruya E, Taniguchi K, et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated hap-loidentical SCT. Bone Marrow Transplant 2012; 47: 508.
5. Focosi D, Zucca A, Scatena F. The role of anti-HLA antibodies in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1585.
6. Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoi-etic stem cell transplantation. Blood 2011; 118: 5957.
7. Gutman JA, Mckinney SK, Pereira S, et al. Prospective monitoring for alloimmuniza-tion in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies. Blood 2009; 87: 415.
8. Ogawa H, Ikegame K, Yoshihara S, et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 2006; 12: 1073.
9. Costa LJ, Moussa O, Bray RA, et al. Overcoming HLA-DPB1 donor specific antibody-mediated haematopoietic graft failure. Br J Haematol 2010; 151: 94.
10. Jordan SC, Quartel AW, Czer LS, et al. Post-transplant therapy using high-dose human immunoglobulin (intravenous gammaglo-bulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998; 66: 800.
11. Lefaucheur C, Nochy D, Andrade J, et al. Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 2009; 9: 1099.
12. Stegall MD, Gloor J, Winters JL, et al. A comparison of plasmapheresis versus highdose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006: 6: 346.
13. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109: 1307.
14. Takai T. Roles of Fc receptors in autoim-munity. Nat Rev Immunol 2002; 2: 580.
15. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484.